Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Gillessena, Silke; Attard, Gerhardt; Beer, Tomasz; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob; Chi, Kim; Clarke, Noel; Davis, Ian; de Bono, Johann; Drake, Charles; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Evans, Christopher; Fanti, Stefano; Feng, Felix; Fizazi, Karim; Frydenberg, Mark; Gleave, Martin; Halabi, Susan; Heidenreich, Axel; Heinrich, Daniel; Higano, Celestia; Hofman, Michael; Hussain, Maha; James, Nicolas; Kanesvaran, Ravindran; Kantoff, Philip; Khauli, Raja; Leibowitz, Raya; Logothetis, Chris; Maluf, Fernando; Millman, Robin; Morgans, Alicia; Morris, Michael; Mottet, Nicolas; Mrabti, Hind; Murphy, Declan; Murthy, Vedang; Oh, William; Ost, Piet; OSullivan, Joe; Padhani, Anwar; Parker, Chris; Poon, Darren; Pritchard, Colin; Reiter, Robert; Roach, Mack; Rubin, Mark; Ryan, Charles; Saad, Fred; Sade, Juan; Sartor, Oliver; Scher, Howard; Shore, Neal; Small, Eric; Smith, Matthew; Soule, Howard; Sternberg, Cora; Steuber, Thomas; Suzuki, Hiroyoshi; Sweeneyh, Christopher; Sydes, Matthew; Taplinh, Mary-Ellen; Tombal, Bertrand; Turkeri, LEVENT; van Oort, Inge; Zapatero, Almudena; Omlind, Aurelius

doi:10.1016/j.eururo.2020.01.012

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Gillessena S., Attard G., Beer T. M., Beltran H., Bjartell A., Bossi A., ...Daha Fazla

European urology, cilt.77, sa.4, ss.508-547, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 77 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.eururo.2020.01.012
Dergi Adı: European urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, Gender Studies Database, MEDLINE
Sayfa Sayıları: ss.508-547
Anahtar Kelimeler: Advanced prostate cancer, High-risk localised prostate cancer, Hormone-sensitive prostate cancer, Castration-resistant prostate cancer, Oligometastatic prostate cancer, Progression-free survival, Overall survival, Prostate cancer treatment, Imaging, Genetics, Tumour genomic profiling, ANDROGEN-DEPRIVATION THERAPY, SALVAGE RADIATION-THERAPY, QUALITY-OF-LIFE, HOT FLASHES, RADICAL PROSTATECTOMY, CLINICAL-TRIALS, FREE SURVIVAL, PHASE-III, TESTOSTERONE MEASUREMENTS, ABIRATERONE ACETATE
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.